new and noteworthy

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2025

This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2025, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).

selected resources

Global Health Aid Cuts

This collection of resources chronicles what recent Trump administration global health aid cuts mean for the future of global health programs and the people who rely on them.

A promotional image for the the KFF Health Policy 101 U.S. Government and Global Health

The U.S. Government and Global Health

In this Health Policy 101 chapter, investigate the U.S. role in global health, including the major initiatives the United States supports, funding levels, and agencies involved in implementing program area efforts.

the essentials

Global Health Trackers

U.S. Global Health Budget Tracker

This tracker provides regularly updated information on U.S. government funding for global health. It includes historical trends and tracks funding levels for U.S. global health efforts through bilateral and multilateral contributions and by program area and agency.

Stay informed.

Stay informed.

Filter

141-150 of 659 results

  • Global Spending on HIV/AIDS in Resource-Poor Settings

    Issue Brief

    This policy brief presents data on the range of resources currently being expended to address the HIV/AIDS epidemic in resource-poor settings, including bilateral, multilateral, and private sector support, as well as domestic spending by recipient country governments. For purposes of this policy brief, resource-poor countries include developing countries and countries in transition. Policy Brief: Other Reports in the Spending on the HIV/AIDS Epidemic Series

  • Ebola: Five Key Questions

    Other Post

    Ebola virus has a unique set of characteristics that determine how and why its spreads, and how deadly it can be. To better understand Ebola, this infographic compares it to twelve other infectious diseases that continue to represent public health challenges today and asks and answers five key questions about the disease.

  • Majorities Across Party Lines Support Investing More Money in Zika Research and Preventing the Virus’ Spread

    News Release

    Democrats More Favorable to ACA in June, Leading to 44% Unfavorable, 42% Favorable Overall Split Majorities of the public say the United States should invest more money in Zika research and in preventing its spread in this country, the latest Kaiser Health Tracking Poll finds. More than seven in 10 people, including majorities of Democrats, Republicans, and independents, say they support investing in Zika research and to prevent its spread. About two thirds of the…

  • About 4 in 10 Adults in the U.S. Are At Greater Risk of Developing Serious Illness if Infected with Coronavirus, Due to Age or Underlying Health Conditions 

    News Release

    Based on current understanding of risk, forty-one percent of adults ages 18 and older in the U.S. have a higher risk of developing more serious illness if they become infected with the virus that causes COVID-19, because they are older or have serious underlying health conditions, or both, according to a new KFF analysis. Of the more than 105 million adults at higher risk if infected with coronavirus, most – 76.3 million, or 72 percent…

  • Virtual Briefing About the Coronavirus Pandemic

    Policy Watch

    KFF's Jen Kates and Josh Michaud discuss the coronavirus outbreak and address questions such as how this epidemic compare to previous ones, how epidemiological models work and how reliable are they, and was China's approach to social distancing more effective? Kates and Michaud on March 30 were featured guests in The Commonwealth Club of California's continuing virtual series on the coronavirus outbreak.

  • Is Contact Tracing Getting Enough Attention in U.S. Coronavirus Response?

    Policy Watch

    This blog examines the role of contact tracing in the U.S. coronavirus response. Contact tracing is going to be a crucial piece of the puzzle for eventually suppressing and containing the virus, allowing people to congregate in public, and letting people go back to work again. But policymakers have, so far, not focused much on scaling up contact tracing capabilities. Capabilities needed include resources and trained staff for traditional contact tracing efforts, which can be…

  • Global Health Diplomacy: Advancing Foreign Policy and Global Health Interests

    Issue Brief

    This article examines the growing attention to global health diplomacy and its future outlook as donor nations continue to face tight budgetary conditions. Authored by Joshua Michaud and Jennifer Kates of the Kaiser Family Foundation, the article was published in the inaugural issue of the Global Health: Science and Practice journal in March 2013. Article

  • CSIS Task Force on HIV/AIDS

    Report

    The Center for Strategic and International Studies (CSIS) Task Force on HIV/AIDS, co-chaired by Senators Bill Frist (R-TN) and Russell Feingold (D-WI), outlines strategic choices that the United States faces in fighting the global HIV/AIDS pandemic. The Task Force seeks to build bipartisan consensus on critical U.S. policy initiatives promoting leadership in strengthening prevention, care, and treatment of HIV/AIDS in affected countries around the world. The Task Force and the Kaiser Family Foundation have collaborated…

  • Financing the Response to AIDS in Low- and MiddleIncome Countries: International Assistance from Donor Governments in 2010

    Report

    This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2010, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).